Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Objective To determine whether intensive combinations of synthetic disease modifying drugs can achieve similar clinical benefits at lower costs to high cost biologics such as tumour necrosis factor inhibitors in patients with active rheumatoid arthritis resistant to initial methotrexate and other sy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ
Main Authors: Scott, David L, Ibrahim, Fowzia, Farewell, Vern, O’Keeffe, Aidan G, Walker, David, Kelly, Clive, Birrell, Fraser, Chakravarty, Kuntal, Maddison, Peter, Heslin, Margaret, Patel, Anita, Kingsley, Gabrielle H
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358851/
https://ncbi.nlm.nih.gov/pubmed/25769495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h1046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados